Le Lézard
Classified in: Covid-19 virus
Subject: Lawsuit

Shareholder Alert: Robbins LLP Reminds Investors of the Class Action Lawsuit Against Eastman Kodak Co. (KODK)


Shareholder rights law firm Robbins LLP reminds investors of the October 13, 2020, deadline to move for lead plaintiff in the class action against Eastman Kodak Co. (NYSE:KODK) for alleged violations of the Securities Exchange Act of 1934 between July 27, 2020 and August 7, 2020. Eastman Kodak is a technology company that provides hardware, software, and services to customers in commercial print, packaging, publishing, manufacturing, and entertainment.

If you suffered a loss in excess of $1 million due to Kodak's misconduct, we encourage you to contact us.

Eastman Kodak Co. (KODK) is Accused of Misleading Shareholders

According to the complaint, on July 27, 2020, Kodak granted its CEO and Executive Chairman 1.75 million stock options, and 45,000 options each to its CFO, VP, and General Counsel. That same day, Kodak issued a statement to media outlets based in Rochester, NY, regarding "a new manufacturing initiative that could change the course of history for Rochester and the American People." Media reports noted there would be a press conference the next day with Pentagon officials and that the initiative involved the U.S. International Development Finance Corporation ("DFC") and the response to COVID-19. On this news, Kodak's trading volume surged and the stock price increased.

On July 28, before the stock market opened, RochesterFirst.com published an article revealing that Kodak and Washington D.C. leaders announced an agreement for a $765 million federal loan to support the launch of Kodak Pharmaceuticals. Kodak executives spent the next several days touting this agreement and watching Kodak's stock price increase over 1,000%, from $2.65 on July 27, to $33.20 on July 29. Simultaneously, the insiders who received options saw their personal worth skyrocket.

On August 1, 2020, questions started to arise regarding Kodak's selection for the federal loan, the way Kodak handled the "inadvertent" disclosure on July 27, and Kodak's failure to disclose the deal to investors. Revelations surrounding these questions caused Kodak's stock to plummet over $29 per share over four trading days. Finally, on August 7, the DFC announced it will not proceed with the loan process until allegations against Kodak are cleared up, causing the stock to drop another 28% to close at $10.73 on August 10, 2020. Kodak is currently under investigation by several House Congressional committees and the SEC.

Kodak (KODK) Shareholders Have Legal Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
[email protected]
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Kodak settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.


These press releases may also interest you

at 07:00
Draganfly Inc. ("Draganfly" or the "Company"), an award-winning, industry-leading drone solutions and systems developer is pleased to announce a memorandum of understanding with Squamish Search and Rescue (SSAR), pursuant to which Draganfly will...

at 07:00
Village Farms International, Inc. ("Village Farms" or "the Company") today announced that it is expanding its executive team with the following new roles: Chief Operating Officer ? Ann Gillin Lefever;President, Global Medical Cannabis ? Paul...

at 06:35
Central Pacific Financial Corp. (the "Company"), parent company of Central Pacific Bank (the "Bank" or "CPB"), today reported net income of $12.9 million, or fully diluted earnings per share ("EPS") of $0.48 for the first quarter of 2024, compared...

at 06:22
Sapiens International Corporation , a leading global provider of software solutions for the insurance industry, announced today that it will report its financial results for the first quarter of 2024 on Tuesday, May 8, 2024. Management will host a...

at 06:05
Thermo Fisher Scientific Inc. , the world leader in serving science, today reported its financial results for the first quarter ended March 30, 2024. First Quarter 2024 Highlights First quarter revenue was $10.34 billion. First quarter GAAP...

at 06:05
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that it will release financial results for the first quarter ended March 31, 2024 after the close of trading on Wednesday, May 8. Biodesix's...



News published on and distributed by: